US Stock MarketDetailed Quotes

Taysha Gene Therapies (TSHA)

Watchlist
  • 5.090
  • +0.310+6.49%
Close Jan 22 16:00 ET
  • 5.070
  • -0.020-0.39%
Post 18:23 ET
1.39BMarket Cap-15.42P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Taysha Gene Therapies (TSHA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-11.80%-24.17M
6.15%-20.18M
-11.22%-22.02M
-11.24%-81.23M
-13.59%-18.31M
-20.42%-21.62M
-14.58%-21.5M
1.92%-19.8M
17.39%-73.02M
-209.55%-16.12M
Net income from continuing operations
-28.24%-32.73M
-28.45%-26.88M
10.52%-21.53M
19.96%-89.3M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
32.80%-111.57M
186.68%47.74M
Operating gains losses
489.33%292K
240.00%273K
-130.27%-102K
-100.04%-16K
99.87%-83K
---75K
---195K
--337K
--36.08M
---64.37M
Depreciation and amortization
-2.72%286K
-13.98%277K
-12.92%283K
-9.19%1.25M
-16.94%304K
-11.18%294K
-6.12%322K
-1.81%325K
16.98%1.37M
1.10%366K
Other non cash items
-51.13%673K
197.17%734K
461.90%590K
-86.48%1.37M
-113.92%-359K
-55.09%1.38M
-93.92%247K
-75.47%105K
191.99%10.14M
349.30%2.58M
Change In working capital
168.53%4.03M
151.99%2.23M
-1,628.86%-4.56M
30.79%-12.47M
46.35%-2.6M
20.20%-5.88M
-437.94%-4.28M
105.96%298K
-197.27%-18.01M
-117.11%-4.85M
-Change in prepaid assets
231.04%971K
-41.36%482K
-51.80%-1.05M
-96.56%207K
-59.11%819K
-121.18%-741K
-9.57%822K
-73.25%-693K
187.88%6.01M
1,754.63%2M
-Change in payables and accrued expense
191.26%3.06M
193.44%3.73M
-127.31%-1.2M
49.36%-4.34M
56.94%-1.4M
45.25%-3.35M
-678.55%-3.99M
3,938.53%4.4M
49.95%-8.57M
39.13%-3.25M
-Change in other working capital
--0
-78.60%-1.99M
32.51%-2.3M
46.07%-8.33M
43.90%-2.02M
62.33%-1.79M
53.57%-1.11M
27.52%-3.41M
-146.04%-15.45M
---3.6M
Cash from discontinued investing activities
Operating cash flow
-11.80%-24.17M
6.15%-20.18M
-11.22%-22.02M
-11.24%-81.23M
-13.59%-18.31M
-20.42%-21.62M
-14.58%-21.5M
1.92%-19.8M
17.39%-73.02M
-209.55%-16.12M
Investing cash flow
Cash flow from continuing investing activities
-37.14%-48K
130.85%62K
-165.00%-371K
95.06%-363K
230.00%13K
99.00%-35K
-518.75%-201K
96.41%-140K
70.51%-7.35M
99.58%-10K
Net PPE purchase and sale
-208.57%-108K
99.00%-2K
-170.00%-378K
90.33%-374K
111.76%2K
---35K
-518.75%-201K
96.41%-140K
81.24%-3.87M
99.26%-17K
Net intangibles purchase and sale
----
----
----
--0
--0
----
----
----
17.65%-3.5M
--0
Net other investing changes
--60K
--64K
--7K
-35.29%11K
----
----
----
----
127.87%17K
--7K
Cash from discontinued investing activities
Investing cash flow
-37.14%-48K
130.85%62K
-165.00%-371K
95.06%-363K
230.00%13K
99.00%-35K
-518.75%-201K
96.41%-140K
70.51%-7.35M
99.58%-10K
Financing cash flow
Cash flow from continuing financing activities
33.39%8.8M
206.93%216.29M
-136.36%-52K
-43.78%76.68M
91.60%-357K
-95.31%6.6M
18,591.78%70.47M
94.05%-22K
161.81%136.39M
-110.30%-4.25M
Net issuance payments of debt
----
----
----
--0
--0
----
----
----
---3.45M
----
Net common stock issuance
-106.82%-454K
----
----
-45.46%76.78M
14.89%-360K
-95.27%6.66M
----
----
164.42%140.79M
-101.02%-423K
Proceeds from stock option exercised by employees
172.82%281K
--0
188.46%75K
30.88%89K
---40K
472.22%103K
--0
-48.00%26K
-73.12%68K
--0
Net other financing activities
-62.28%-271K
1,007.69%118K
-164.58%-127K
81.77%-185K
111.47%43K
-72.16%-167K
89.43%-13K
88.57%-48K
27.50%-1.02M
-0.81%-375K
Cash from discontinued financing activities
Financing cash flow
33.39%8.8M
206.93%216.29M
-136.36%-52K
-43.78%76.68M
91.60%-357K
-95.31%6.6M
18,591.78%70.47M
94.05%-22K
161.81%136.39M
-110.30%-4.25M
Net cash flow
Beginning cash position
79.85%315.36M
-5.84%119.19M
-3.35%141.64M
61.89%146.54M
-3.97%160.29M
267.44%175.34M
91.61%126.58M
61.89%146.54M
-40.35%90.52M
351.82%166.92M
Current changes in cash
-2.40%-15.42M
302.29%196.17M
-12.44%-22.44M
-108.75%-4.9M
8.46%-18.65M
-112.63%-15.06M
365.85%48.76M
18.38%-19.96M
191.51%56.02M
-138.03%-20.38M
End cash Position
87.13%299.94M
79.85%315.36M
-5.84%119.19M
-3.35%141.64M
-3.35%141.64M
-3.97%160.29M
267.44%175.34M
91.61%126.58M
61.89%146.54M
61.89%146.54M
Free cash flow
-12.12%-24.27M
7.01%-20.18M
-12.34%-22.4M
-1.51%-81.6M
-13.46%-18.31M
-0.94%-21.65M
-15.95%-21.71M
17.22%-19.94M
29.02%-80.39M
-230.08%-16.13M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -11.80%-24.17M6.15%-20.18M-11.22%-22.02M-11.24%-81.23M-13.59%-18.31M-20.42%-21.62M-14.58%-21.5M1.92%-19.8M17.39%-73.02M-209.55%-16.12M
Net income from continuing operations -28.24%-32.73M-28.45%-26.88M10.52%-21.53M19.96%-89.3M-139.35%-18.79M78.20%-25.52M14.92%-20.93M-36.54%-24.06M32.80%-111.57M186.68%47.74M
Operating gains losses 489.33%292K240.00%273K-130.27%-102K-100.04%-16K99.87%-83K---75K---195K--337K--36.08M---64.37M
Depreciation and amortization -2.72%286K-13.98%277K-12.92%283K-9.19%1.25M-16.94%304K-11.18%294K-6.12%322K-1.81%325K16.98%1.37M1.10%366K
Other non cash items -51.13%673K197.17%734K461.90%590K-86.48%1.37M-113.92%-359K-55.09%1.38M-93.92%247K-75.47%105K191.99%10.14M349.30%2.58M
Change In working capital 168.53%4.03M151.99%2.23M-1,628.86%-4.56M30.79%-12.47M46.35%-2.6M20.20%-5.88M-437.94%-4.28M105.96%298K-197.27%-18.01M-117.11%-4.85M
-Change in prepaid assets 231.04%971K-41.36%482K-51.80%-1.05M-96.56%207K-59.11%819K-121.18%-741K-9.57%822K-73.25%-693K187.88%6.01M1,754.63%2M
-Change in payables and accrued expense 191.26%3.06M193.44%3.73M-127.31%-1.2M49.36%-4.34M56.94%-1.4M45.25%-3.35M-678.55%-3.99M3,938.53%4.4M49.95%-8.57M39.13%-3.25M
-Change in other working capital --0-78.60%-1.99M32.51%-2.3M46.07%-8.33M43.90%-2.02M62.33%-1.79M53.57%-1.11M27.52%-3.41M-146.04%-15.45M---3.6M
Cash from discontinued investing activities
Operating cash flow -11.80%-24.17M6.15%-20.18M-11.22%-22.02M-11.24%-81.23M-13.59%-18.31M-20.42%-21.62M-14.58%-21.5M1.92%-19.8M17.39%-73.02M-209.55%-16.12M
Investing cash flow
Cash flow from continuing investing activities -37.14%-48K130.85%62K-165.00%-371K95.06%-363K230.00%13K99.00%-35K-518.75%-201K96.41%-140K70.51%-7.35M99.58%-10K
Net PPE purchase and sale -208.57%-108K99.00%-2K-170.00%-378K90.33%-374K111.76%2K---35K-518.75%-201K96.41%-140K81.24%-3.87M99.26%-17K
Net intangibles purchase and sale --------------0--0------------17.65%-3.5M--0
Net other investing changes --60K--64K--7K-35.29%11K----------------127.87%17K--7K
Cash from discontinued investing activities
Investing cash flow -37.14%-48K130.85%62K-165.00%-371K95.06%-363K230.00%13K99.00%-35K-518.75%-201K96.41%-140K70.51%-7.35M99.58%-10K
Financing cash flow
Cash flow from continuing financing activities 33.39%8.8M206.93%216.29M-136.36%-52K-43.78%76.68M91.60%-357K-95.31%6.6M18,591.78%70.47M94.05%-22K161.81%136.39M-110.30%-4.25M
Net issuance payments of debt --------------0--0---------------3.45M----
Net common stock issuance -106.82%-454K---------45.46%76.78M14.89%-360K-95.27%6.66M--------164.42%140.79M-101.02%-423K
Proceeds from stock option exercised by employees 172.82%281K--0188.46%75K30.88%89K---40K472.22%103K--0-48.00%26K-73.12%68K--0
Net other financing activities -62.28%-271K1,007.69%118K-164.58%-127K81.77%-185K111.47%43K-72.16%-167K89.43%-13K88.57%-48K27.50%-1.02M-0.81%-375K
Cash from discontinued financing activities
Financing cash flow 33.39%8.8M206.93%216.29M-136.36%-52K-43.78%76.68M91.60%-357K-95.31%6.6M18,591.78%70.47M94.05%-22K161.81%136.39M-110.30%-4.25M
Net cash flow
Beginning cash position 79.85%315.36M-5.84%119.19M-3.35%141.64M61.89%146.54M-3.97%160.29M267.44%175.34M91.61%126.58M61.89%146.54M-40.35%90.52M351.82%166.92M
Current changes in cash -2.40%-15.42M302.29%196.17M-12.44%-22.44M-108.75%-4.9M8.46%-18.65M-112.63%-15.06M365.85%48.76M18.38%-19.96M191.51%56.02M-138.03%-20.38M
End cash Position 87.13%299.94M79.85%315.36M-5.84%119.19M-3.35%141.64M-3.35%141.64M-3.97%160.29M267.44%175.34M91.61%126.58M61.89%146.54M61.89%146.54M
Free cash flow -12.12%-24.27M7.01%-20.18M-12.34%-22.4M-1.51%-81.6M-13.46%-18.31M-0.94%-21.65M-15.95%-21.71M17.22%-19.94M29.02%-80.39M-230.08%-16.13M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -